Candelanza, Jessa Mae G.
HRN: 21-72-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/07/2025
10/14/2025
ORAL
8ml
TID
AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes